HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Local Selected Research

APTO-253

1/2018APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells.
1/2018APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Local Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 01/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Lymphoma (Lymphomas)
01/2018
1Hypersensitivity (Allergy)
01/2018

Drug/Important Bio-Agent (IBA)

2APTO-253IBA
01/2018 - 01/2018
1Phosphotransferases (Kinase)IBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018
1olaparibIBA
01/2018